BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29071747)

  • 1. The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review.
    Shunkwiler SM; Pham HP; Wool G; Ipe TS; Fang DC; Biller E; Treml A; Weiss J; Baron BW; Berg M;
    J Clin Apher; 2018 Jun; 33(3):371-379. PubMed ID: 29071747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of systemic unfractionated heparin anticoagulation during therapeutic plasma exchange.
    Kaplan A; Raut P; Totoe G; Morgan S; Zantek ND
    J Clin Apher; 2016 Dec; 31(6):507-515. PubMed ID: 26752590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review.
    Hodulik KL; Root AG; Ledbetter LS; Onwuemene OA
    Transfusion; 2019 May; 59(5):1870-1879. PubMed ID: 30762882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane therapeutic plasma exchange with and without heparin anticoagulation.
    Brunetta Gavranić B; Bašić-Jukić N; Premužić V; Kes P
    J Clin Apher; 2017 Dec; 32(6):479-485. PubMed ID: 28485027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis management and therapeutic plasma exchange: Results of a practice survey.
    Zantek ND; Boral LI; Li Y; Yamada C; Svensson AM; Crane JE; Smith RE; Pagano MB; Rollins-Raval MA; Schmidt AE; Wong ECC; Wu Y
    J Clin Apher; 2018 Oct; 33(5):604-610. PubMed ID: 30207610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis testing and therapeutic plasma exchange: Results of a practice survey.
    Zantek ND; Pagano MB; Rollins-Raval MA; Smith RE; Schmidt AE; Crane JE; Boral LI; Li Y; Svensson AM; Yamada C; Wu Y; Wong ECC
    J Clin Apher; 2019 Feb; 34(1):26-32. PubMed ID: 30375048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange.
    Michaud D; McKay L; Pfefferle P; Komant T
    Dynamics; 2001; 12(4):18-24. PubMed ID: 11845483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patients.
    Zhang R; Dahl AB; Marchant B; Jackups RR; Karnes HE; Shah P; Dynis M; Thibodeaux SR; Despotis GJ
    J Clin Apher; 2020 Jan; 35(1):41-49. PubMed ID: 31713919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic plasma exchange: a technical and operational review.
    Kaplan AA
    J Clin Apher; 2013 Feb; 28(1):3-10. PubMed ID: 23420589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic effects of therapeutic plasma exchange: A concise review.
    Soares Ferreira Júnior A; Hodulik K; Barton KD; Onwuemene OA
    J Clin Apher; 2022 Jun; 37(3):292-312. PubMed ID: 35196407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessions.
    Córdoba JP; Larrarte C; Medina MC
    J Clin Apher; 2015 Dec; 30(6):347-52. PubMed ID: 25708454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-based therapeutic plasma exchange in dogs: Prescription, anticoagulation, and metabolic response.
    Francey T; Schweighauser A
    J Vet Intern Med; 2019 Jul; 33(4):1635-1645. PubMed ID: 31115107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.
    Nutescu EA; Spinler SA; Dager WE; Bussey HI
    Pharmacotherapy; 2004 Oct; 24(10 Pt 2):199S-202S. PubMed ID: 15624340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis.
    Yamada C; Pham HP; Wu Y; Cooling L; Kim HC; Morgan S; Schwartz J; Winters JL; Wong EC
    J Clin Apher; 2017 Feb; 32(1):5-11. PubMed ID: 26946363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report of Severe Antithrombin Deficiency During Extracorporeal Membrane Oxygenation and Therapeutic Plasma Exchange for Double Lung Transplantation.
    Williams B; Mazzeffi MA; Sanchez PG; Pham SM; Kon Z; Tanaka KA
    A A Case Rep; 2017 Jan; 8(1):11-13. PubMed ID: 28036320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.
    Onwuemene OA; Zantek ND; Rollins-Raval MA; Raval JS; Kiss JE; Ipe TS; Kuchibhatla M; Pagano MB; Wong ECC
    J Clin Apher; 2019 Oct; 34(5):545-554. PubMed ID: 31116461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on haemostasis of different replacement fluids during therapeutic plasma exchange-A comparative multicentre observational study.
    Kohli R; Allen E; Platton S; Griffin J; Manson L; MacCallum P; Green L
    J Clin Apher; 2022 Dec; 37(6):534-543. PubMed ID: 36054584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology consultation on anticoagulation monitoring: factor X-related assays.
    Wool GD; Lu CM;
    Am J Clin Pathol; 2013 Nov; 140(5):623-34. PubMed ID: 24124140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of the patient receiving therapeutic plasma exchange (TPE).
    Wolff T
    J Clin Apher; 1985; 2(4):378-80. PubMed ID: 4066636
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM).
    Thölking G; Mesters R; Dittrich R; Pavenstädt H; Kümpers P; Reuter S
    PLoS One; 2015; 10(6):e0130402. PubMed ID: 26121484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.